35% lavere efter administration af Atripla på tom mave sammenlignet med den individuelle komponent tenofovirdisoproxilfumarat, når denne tages sammen med mad.
It is anticipated that tenofovir exposure will be approximately 35% lower following administration of Atripla on an empty stomach as compared to the individual component tenofovir disoproxil fumarate when taken with food.